Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Roche
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:CEO |
gptkb:Cindy_Perettie
|
| gptkbp:foundedYear |
2010
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Foundation Medicine (2018)
|
| gptkbp:industry |
gptkb:biotechnology
healthcare |
| gptkbp:name |
gptkb:Foundation_Medicine
|
| gptkbp:parentCompany |
gptkb:Roche
|
| gptkbp:product |
gptkb:FoundationACT
gptkb:FoundationOne_CDx gptkb:FoundationOne_Liquid |
| gptkbp:publiclyTraded |
no
|
| gptkbp:specializesIn |
molecular diagnostics
cancer genomics |
| gptkbp:status |
gptkb:subsidiary
|
| gptkbp:website |
https://www.foundationmedicine.com/
|
| gptkbp:bfsParent |
gptkb:Roche
|
| gptkbp:bfsLayer |
6
|